Free Trial

Rodman & Renshaw Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Rodman & Renshaw. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Rodman & Renshaw.

Average Return
00.00% 12-Month ROI
Total Ratings
25 Last 12 Months
Buy Ratings
23 Last 12 Months
Sell Ratings
0 Last 12 Months
Companies Covered
25 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
BioXcel Therapeutics, Inc. stock logo
BTAI
BioXcel Therapeutics
$3.11
-8.3%
3/19/2025Initiated Coverage$65.00BuyView details for Rodman & Renshaw rating of BioXcel Therapeutics (NASDAQ:BTAI) on 3/19/2025
Telomir Pharmaceuticals, Inc. stock logo
TELO
Telomir Pharmaceuticals
$1.36
-0.7%
2/21/2025 Initiated Coverage$15.00BuyView details for Rodman & Renshaw rating of Telomir Pharmaceuticals (NASDAQ:TELO) on 2/21/2025
Talphera, Inc. stock logo
TLPH
Talphera
$0.94
-5.6%
1/28/2025 Initiated Coverage$4.00BuyView details for Rodman & Renshaw rating of Talphera (NASDAQ:TLPH) on 1/28/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
$3.47
+0.6%
1/28/2025 Initiated Coverage$13.00BuyView details for Rodman & Renshaw rating of PolyPid (NASDAQ:PYPD) on 1/28/2025
INmune Bio, Inc. stock logo
INMB
INmune Bio
$2.01
+2.0%
1/28/2025 Initiated Coverage$23.00BuyView details for Rodman & Renshaw rating of INmune Bio (NASDAQ:INMB) on 1/28/2025
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$1.07
1/28/2025 Initiated Coverage$7.00BuyView details for Rodman & Renshaw rating of Cardiol Therapeutics (NASDAQ:CRDL) on 1/28/2025
Atara Biotherapeutics, Inc. stock logo
ATRA
Atara Biotherapeutics
$12.12
-0.3%
12/20/2024 Initiated Coverage$25.00BuyView details for Rodman & Renshaw rating of Atara Biotherapeutics (NASDAQ:ATRA) on 12/20/2024
TuHURA Biosciences, Inc. stock logo
HURA
TuHURA Biosciences
$2.50
-3.5%
12/19/2024 Initiated Coverage$11.00BuyView details for Rodman & Renshaw rating of TuHURA Biosciences (NASDAQ:HURA) on 12/19/2024
FibroBiologics Inc. stock logo
FBLG
FibroBiologics
$0.54
-3.9%
12/12/2024 Initiated Coverage$12.00BuyView details for Rodman & Renshaw rating of FibroBiologics (NASDAQ:FBLG) on 12/12/2024
Tharimmune, Inc. stock logo
THAR
Tharimmune
$3.14
+0.3%
12/6/2024 Initiated Coverage$17.00BuyView details for Rodman & Renshaw rating of Tharimmune (NASDAQ:THAR) on 12/6/2024
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$1.62
-4.1%
11/14/2024 Initiated Coverage$5.00BuyView details for Rodman & Renshaw rating of Rockwell Medical (NASDAQ:RMTI) on 11/14/2024
Omeros Corporation stock logo
OMER
Omeros
$4.15
-1.2%
11/14/2024 Initiated Coverage$9.00BuyView details for Rodman & Renshaw rating of Omeros (NASDAQ:OMER) on 11/14/2024
Eupraxia Pharmaceuticals Inc. stock logo
EPRX
Eupraxia Pharmaceuticals
$5.33
-2.6%
11/14/2024 Initiated Coverage$9.00BuyView details for Rodman & Renshaw rating of Eupraxia Pharmaceuticals (NASDAQ:EPRX) on 11/14/2024
Achieve Life Sciences, Inc. stock logo
ACHV
Achieve Life Sciences
$3.08
-2.5%
11/14/2024 Initiated Coverage$12.00BuyView details for Rodman & Renshaw rating of Achieve Life Sciences (NASDAQ:ACHV) on 11/14/2024
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
$11.62
-3.0%
11/5/2024 Initiated Coverage$48.00BuyView details for Rodman & Renshaw rating of Bicara Therapeutics (NASDAQ:BCAX) on 11/5/2024
Quince Therapeutics, Inc. stock logo
QNCX
Quince Therapeutics
$1.60
+1.3%
10/29/2024 Initiated Coverage$11.00BuyView details for Rodman & Renshaw rating of Quince Therapeutics (NASDAQ:QNCX) on 10/29/2024
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
$3.88
-1.2%
10/23/2024 DowngradeBuyNeutralView details for Rodman & Renshaw rating of Alto Neuroscience (NYSE:ANRO) on 10/23/2024
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
$49.22
+3.3%
10/11/2024 Initiated Coverage$50.00BuyView details for Rodman & Renshaw rating of Monopar Therapeutics (NASDAQ:MNPR) on 10/11/2024
Nkarta, Inc. stock logo
NKTX
Nkarta
$1.97
-4.8%
10/9/2024 Initiated Coverage$14.00BuyView details for Rodman & Renshaw rating of Nkarta (NASDAQ:NKTX) on 10/9/2024
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
$3.92
-5.5%
10/9/2024 Initiated Coverage$16.00BuyView details for Rodman & Renshaw rating of Kyverna Therapeutics (NASDAQ:KYTX) on 10/9/2024
MIRA Pharmaceuticals, Inc. stock logo
MIRA
MIRA Pharmaceuticals
$1.45
-12.7%
9/30/2024 Initiated Coverage$17.00BuyView details for Rodman & Renshaw rating of MIRA Pharmaceuticals (NASDAQ:MIRA) on 9/30/2024
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
$1.93
-2.5%
9/26/2024 Upgrade$18.00NeutralBuyView details for Rodman & Renshaw rating of Biomea Fusion (NASDAQ:BMEA) on 9/26/2024
Emergent Biosolutions Inc. stock logo
EBS
Emergent Biosolutions
$8.15
-1.0%
9/13/2024 Reiterated Rating$16.00 ➝ $16.00BuyView details for Rodman & Renshaw rating of Emergent Biosolutions (NYSE:EBS) on 9/13/2024
Athira Pharma, Inc. stock logo
ATHA
Athira Pharma
$0.36
-5.8%
9/4/2024 DowngradeBuyNeutralView details for Rodman & Renshaw rating of Athira Pharma (NASDAQ:ATHA) on 9/4/2024
Passage Bio, Inc. stock logo
PASG
Passage Bio
$7.00
+0.4%
9/3/2024 Initiated Coverage$140.00BuyView details for Rodman & Renshaw rating of Passage Bio (NASDAQ:PASG) on 9/3/2024
CorMedix Inc stock logo
CRMD
CorMedix
$12.94
-1.1%
8/26/2024 Initiated Coverage$13.00BuyView details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 8/26/2024
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
$1.96
+2.6%
8/22/2024 Initiated Coverage$9.00BuyView details for Rodman & Renshaw rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 8/22/2024
Journey Medical Corporation stock logo
DERM
Journey Medical
$7.11
-3.3%
8/22/2024 Initiated Coverage$9.00BuyView details for Rodman & Renshaw rating of Journey Medical (NASDAQ:DERM) on 8/22/2024
Emergent Biosolutions Inc. stock logo
EBS
Emergent Biosolutions
$8.15
-1.0%
8/22/2024 Initiated Coverage$16.00BuyView details for Rodman & Renshaw rating of Emergent Biosolutions (NYSE:EBS) on 8/22/2024
Athira Pharma, Inc. stock logo
ATHA
Athira Pharma
$0.36
-5.8%
8/19/2024 Initiated Coverage$22.00BuyView details for Rodman & Renshaw rating of Athira Pharma (NASDAQ:ATHA) on 8/19/2024
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
$2.11
-2.3%
8/8/2024 Reiterated Rating$107.00 ➝ $107.00BuyView details for Rodman & Renshaw rating of Cassava Sciences (NASDAQ:SAVA) on 8/8/2024
Century Therapeutics, Inc. stock logo
IPSC
Century Therapeutics
$0.50
-3.4%
8/8/2024 Initiated Coverage$6.00BuyView details for Rodman & Renshaw rating of Century Therapeutics (NASDAQ:IPSC) on 8/8/2024
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$56.26
+0.7%
8/2/2024 Initiated Coverage$90.00BuyView details for Rodman & Renshaw rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/2/2024
Annovis Bio, Inc. stock logo
ANVS
Annovis Bio
$2.49
+4.2%
7/2/2024 Reiterated Rating$67.00 ➝ $67.00BuyView details for Rodman & Renshaw rating of Annovis Bio (NYSE:ANVS) on 7/2/2024
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
$2.17
-8.1%
7/2/2024 Reiterated Rating$14.00 ➝ $14.00BuyView details for Rodman & Renshaw rating of Cognition Therapeutics (NASDAQ:CGTX) on 7/2/2024
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
$48.68
+3.1%
6/28/2024 Initiated Coverage$30.00BuyView details for Rodman & Renshaw rating of Nektar Therapeutics (NASDAQ:NKTR) on 6/28/2024
Leap Therapeutics, Inc. stock logo
LPTX
Leap Therapeutics
$0.30
+4.7%
6/28/2024 Initiated Coverage$8.00BuyView details for Rodman & Renshaw rating of Leap Therapeutics (NASDAQ:LPTX) on 6/28/2024
Mural Oncology PLC stock logo
MURA
Mural Oncology
$2.08
+0.5%
6/28/2024 Initiated Coverage$15.00BuyView details for Rodman & Renshaw rating of Mural Oncology (NASDAQ:MURA) on 6/28/2024
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
$3.22
-5.3%
6/26/2024 Initiated Coverage$16.00BuyView details for Rodman & Renshaw rating of Sana Biotechnology (NASDAQ:SANA) on 6/26/2024
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
$3.88
-1.2%
6/21/2024 Initiated Coverage$43.00BuyView details for Rodman & Renshaw rating of Alto Neuroscience (NYSE:ANRO) on 6/21/2024
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
$6.05
-2.6%
6/13/2024 Initiated Coverage$18.00BuyView details for Rodman & Renshaw rating of Coya Therapeutics (NASDAQ:COYA) on 6/13/2024
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
$8.25
-15.4%
6/13/2024 Initiated Coverage$7.00BuyView details for Rodman & Renshaw rating of Trevi Therapeutics (NASDAQ:TRVI) on 6/13/2024
Scilex Holding Company stock logo
SCLX
Scilex
$26.28
+3.6%
6/13/2024 Initiated Coverage$455.00BuyView details for Rodman & Renshaw rating of Scilex (NASDAQ:SCLX) on 6/13/2024
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
$0.50
-1.0%
6/13/2024 Initiated Coverage$10.00BuyView details for Rodman & Renshaw rating of Rani Therapeutics (NASDAQ:RANI) on 6/13/2024
MannKind Corporation stock logo
MNKD
MannKind
$5.57
+2.8%
6/13/2024 Initiated Coverage$8.00BuyView details for Rodman & Renshaw rating of MannKind (NASDAQ:MNKD) on 6/13/2024
Heron Therapeutics, Inc. stock logo
HRTX
Heron Therapeutics
$1.26
-1.6%
6/13/2024 Initiated Coverage$7.00BuyView details for Rodman & Renshaw rating of Heron Therapeutics (NASDAQ:HRTX) on 6/13/2024
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
$15.40
-2.9%
6/12/2024 Initiated Coverage$27.00BuyView details for Rodman & Renshaw rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 6/12/2024
Annovis Bio, Inc. stock logo
ANVS
Annovis Bio
$2.49
+4.2%
6/4/2024 Initiated Coverage$67.00BuyView details for Rodman & Renshaw rating of Annovis Bio (NYSE:ANVS) on 6/4/2024
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
8/10/2017 Reiterated Rating$17.00NeutralView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 8/10/2017
CorMedix Inc stock logo
CRMD
CorMedix
$12.94
-1.1%
8/10/2017 Lower Price Target$25.00 ➝ $15.00BuyView details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 8/10/2017
Gevo, Inc. stock logo
GEVO
Gevo
$1.67
+0.6%
8/9/2017 Reiterated Rating$240.00BuyView details for Rodman & Renshaw rating of Gevo (NASDAQ:GEVO) on 8/9/2017
Veru Inc. stock logo
VERU
Veru
$3.45
-3.1%
7/26/2017 Initiated Coverage$50.00BuyView details for Rodman & Renshaw rating of Veru (NASDAQ:VERU) on 7/26/2017
Plug Power, Inc. stock logo
PLUG
Plug Power
$1.52
+0.7%
7/24/2017 Reiterated Rating$4.00BuyView details for Rodman & Renshaw rating of Plug Power (NASDAQ:PLUG) on 7/24/2017
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
$6.36
-1.2%
7/22/2017 Reiterated Rating$2.15BuyView details for Rodman & Renshaw rating of Capricor Therapeutics (NASDAQ:CAPR) on 7/22/2017
BeyondSpring Inc. stock logo
BYSI
BeyondSpring
$1.82
-2.7%
7/14/2017 Boost Price Target$43.00 ➝ $50.00BuyView details for Rodman & Renshaw rating of BeyondSpring (NASDAQ:BYSI) on 7/14/2017
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
$3.89
+1.6%
7/11/2017 Initiated Coverage$165.00BuyView details for Rodman & Renshaw rating of Fortress Biotech (NASDAQ:FBIO) on 7/11/2017
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$13.35
+0.2%
5/30/2017 Initiated Coverage$800.00BuyView details for Rodman & Renshaw rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 5/30/2017
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$1.81
+4.0%
5/23/2017 Reiterated Rating$50.00BuyView details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 5/23/2017
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$23.61
-2.4%
5/22/2017 Reiterated Rating$60.00BuyView details for Rodman & Renshaw rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/22/2017
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
5/19/2017 Reiterated Rating$17.00NeutralView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 5/19/2017
Magic Software Enterprises Ltd. stock logo
MGIC
Magic Software Enterprises
$20.43
5/17/2017 Reiterated Rating$9.00 ➝ $10.00BuyView details for Rodman & Renshaw rating of Magic Software Enterprises (NASDAQ:MGIC) on 5/17/2017
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$2.27
-6.2%
5/10/2017 Initiated Coverage$13.00BuyView details for Rodman & Renshaw rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 5/10/2017
CorMedix Inc stock logo
CRMD
CorMedix
$12.94
-1.1%
5/5/2017 Lower Price Target$30.00 ➝ $25.00BuyView details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 5/5/2017
American Superconductor Corporation stock logo
AMSC
American Superconductor
$56.32
+2.9%
4/28/2017 Reiterated Rating$10.00 ➝ $7.50BuyView details for Rodman & Renshaw rating of American Superconductor (NASDAQ:AMSC) on 4/28/2017
Barrick Mining Corporation stock logo
B
Barrick Mining
C$29.05
-1.2%
4/24/2017 Boost Price TargetC$4.25 ➝ C$4.50BuyView details for Rodman & Renshaw rating of Barrick Mining (NYSE:B) on 4/24/2017
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$1.81
+4.0%
4/17/2017 Boost Price Target$40.00 ➝ $50.00BuyView details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 4/17/2017
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$1.81
+4.0%
4/17/2017 Reiterated Rating$40.00 ➝ $50.00BuyView details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 4/17/2017
Plug Power, Inc. stock logo
PLUG
Plug Power
$1.52
+0.7%
4/6/2017 Boost Price Target$3.00 ➝ $4.00BuyView details for Rodman & Renshaw rating of Plug Power (NASDAQ:PLUG) on 4/6/2017
BeyondSpring Inc. stock logo
BYSI
BeyondSpring
$1.82
-2.7%
4/4/2017 Initiated Coverage$43.00BuyView details for Rodman & Renshaw rating of BeyondSpring (NASDAQ:BYSI) on 4/4/2017
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$51.13
-4.1%
3/23/2017 Reiterated Rating$25.00BuyView details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 3/23/2017
Harrow, Inc. stock logo
HROW
Harrow
$39.42
-0.1%
3/22/2017 Reiterated Rating$5.00BuyView details for Rodman & Renshaw rating of Harrow (NASDAQ:HROW) on 3/22/2017
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$51.13
-4.1%
3/8/2017 Initiated Coverage$25.00BuyView details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 3/8/2017
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
3/6/2017 Lower Price Target$23.00 ➝ $17.00NeutralView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 3/6/2017
Magic Software Enterprises Ltd. stock logo
MGIC
Magic Software Enterprises
$20.43
3/6/2017 Reiterated Rating$8.00 ➝ $9.00BuyView details for Rodman & Renshaw rating of Magic Software Enterprises (NASDAQ:MGIC) on 3/6/2017
Quest Resource Holding Corporation. stock logo
QRHC
Quest Resource
$1.64
-2.4%
3/6/2017 Initiated Coverage$5.00BuyView details for Rodman & Renshaw rating of Quest Resource (NASDAQ:QRHC) on 3/6/2017
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
2/27/2017 Reiterated Rating$23.00 ➝ $17.00NeutralView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 2/27/2017
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
$6.36
-1.2%
2/13/2017 Initiated Coverage$14.00BuyView details for Rodman & Renshaw rating of Capricor Therapeutics (NASDAQ:CAPR) on 2/13/2017
BioLineRx Ltd. stock logo
BLRX
BioLineRx
$4.04
+0.7%
2/13/2017 Initiated Coverage$120.00BuyView details for Rodman & Renshaw rating of BioLineRx (NASDAQ:BLRX) on 2/13/2017
Abeona Therapeutics Inc. stock logo
ABEO
Abeona Therapeutics
$6.43
-4.7%
2/7/2017Reiterated Rating$425.00 ➝ $500.00BuyView details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 2/7/2017
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
1/31/2017 DowngradeBuyNeutralView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 1/31/2017
Avino Silver & Gold Mines Ltd. stock logo
ASM
Avino Silver & Gold Mines
C$4.37
-0.2%
1/24/2017 Boost Price TargetC$3.50 ➝ C$4.00BuyView details for Rodman & Renshaw rating of Avino Silver & Gold Mines (NYSE:ASM) on 1/24/2017
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$9.61
-0.1%
1/3/2017 Initiated Coverage$6.00BuyView details for Rodman & Renshaw rating of Niagen Bioscience (NASDAQ:NAGE) on 1/3/2017
Plug Power, Inc. stock logo
PLUG
Plug Power
$1.52
+0.7%
12/6/2016 Initiated Coverage$3.00BuyView details for Rodman & Renshaw rating of Plug Power (NASDAQ:PLUG) on 12/6/2016
Barrick Mining Corporation stock logo
B
Barrick Mining
C$29.05
-1.2%
11/28/2016 Boost Price TargetC$4.00 ➝ C$4.25BuyView details for Rodman & Renshaw rating of Barrick Mining (NYSE:B) on 11/28/2016
Harrow, Inc. stock logo
HROW
Harrow
$39.42
-0.1%
11/28/2016 Initiated Coverage$5.00BuyView details for Rodman & Renshaw rating of Harrow (NASDAQ:HROW) on 11/28/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
11/10/2016Downgrade$81.00 ➝ $23.00BuyNeutralView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 11/10/2016
DURECT Corporation stock logo
DRRX
DURECT
$1.91
9/27/2016Reiterated Rating$40.00 ➝ $35.00BuyView details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 9/27/2016
Aytu BioPharma Inc. stock logo
AYTU
Aytu BioPharma
$2.36
+2.6%
9/26/2016 Initiated Coverage$9.00BuyView details for Rodman & Renshaw rating of Aytu BioPharma (NASDAQ:AYTU) on 9/26/2016
Clean Energy Fuels Corp. stock logo
CLNE
Clean Energy Fuels
$2.40
-5.1%
9/23/2016 Reiterated Rating$5.00 ➝ $6.30BuyView details for Rodman & Renshaw rating of Clean Energy Fuels (NASDAQ:CLNE) on 9/23/2016
Hecla Mining Company stock logo
HL
Hecla Mining
$11.22
+0.6%
9/6/2016 Initiated Coverage$9.00BuyView details for Rodman & Renshaw rating of Hecla Mining (NYSE:HL) on 9/6/2016
DarioHealth Corp. stock logo
DRIO
DarioHealth
$7.11
+0.3%
8/22/2016Reiterated Rating$240.00BuyView details for Rodman & Renshaw rating of DarioHealth (NASDAQ:DRIO) on 8/22/2016
Oramed Pharmaceuticals Inc. stock logo
ORMP
Oramed Pharmaceuticals
$2.41
-0.8%
8/21/2016Reiterated Rating$25.00BuyView details for Rodman & Renshaw rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 8/21/2016
Abeona Therapeutics Inc. stock logo
ABEO
Abeona Therapeutics
$6.43
-4.7%
8/21/2016 Reiterated Rating$425.00BuyView details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 8/21/2016
Energy Focus, Inc. stock logo
EFOI
Energy Focus
$2.48
8/15/2016 Boost Price Target$280.00 ➝ $560.00BuyView details for Rodman & Renshaw rating of Energy Focus (NASDAQ:EFOI) on 8/15/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
8/9/2016Lower Price Target$90.00 ➝ $81.00BuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 8/9/2016
Abeona Therapeutics Inc. stock logo
ABEO
Abeona Therapeutics
$6.43
-4.7%
8/5/2016 Reiterated Rating$425.00BuyView details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 8/5/2016
DURECT Corporation stock logo
DRRX
DURECT
$1.91
8/3/2016Reiterated Rating$40.00BuyView details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 8/3/2016
Ekso Bionics Holdings, Inc. stock logo
EKSO
Ekso Bionics
$3.83
-2.3%
7/31/2016 Reiterated RatingBuyView details for Rodman & Renshaw rating of Ekso Bionics (NASDAQ:EKSO) on 7/31/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
7/28/2016Reiterated Rating$90.00BuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 7/28/2016
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
$8.19
-7.1%
7/18/2016 Reiterated RatingBuyView details for Rodman & Renshaw rating of Kura Oncology (NASDAQ:KURA) on 7/18/2016
Ford Motor Company stock logo
F
Ford Motor
$11.68
-0.7%
7/18/2016 Initiated CoverageBuyView details for Rodman & Renshaw rating of Ford Motor (NYSE:F) on 7/18/2016
Orion Energy Systems, Inc. stock logo
OESX
Orion Energy Systems
$8.91
+0.8%
7/18/2016 Initiated Coverage$25.00BuyView details for Rodman & Renshaw rating of Orion Energy Systems (NASDAQ:OESX) on 7/18/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
7/17/2016Reiterated Rating$90.00BuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 7/17/2016
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$1.81
+4.0%
7/11/2016Reiterated RatingBuyView details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 7/11/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
7/6/2016Reiterated Rating$90.00BuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 7/6/2016
DURECT Corporation stock logo
DRRX
DURECT
$1.91
7/6/2016Reiterated Rating$40.00BuyView details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 7/6/2016
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
$12.49
-0.5%
6/30/2016 Initiated Coverage$5,250.00BuyView details for Rodman & Renshaw rating of Crescent Biopharma (NASDAQ:CBIO) on 6/30/2016
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$2.38
-10.2%
6/21/2016 Reiterated Rating$2,448.00BuyView details for Rodman & Renshaw rating of Inovio Pharmaceuticals (NASDAQ:INO) on 6/21/2016
Westport Fuel Systems Inc. stock logo
WPRT
Westport Fuel Systems
$2.35
-1.3%
6/20/2016 Initiated Coverage$50.00BuyView details for Rodman & Renshaw rating of Westport Fuel Systems (NASDAQ:WPRT) on 6/20/2016
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
$8.19
-7.1%
5/24/2016 Reiterated RatingBuyView details for Rodman & Renshaw rating of Kura Oncology (NASDAQ:KURA) on 5/24/2016
DarioHealth Corp. stock logo
DRIO
DarioHealth
$7.11
+0.3%
5/24/2016Reiterated Rating$240.00BuyView details for Rodman & Renshaw rating of DarioHealth (NASDAQ:DRIO) on 5/24/2016
Abeona Therapeutics Inc. stock logo
ABEO
Abeona Therapeutics
$6.43
-4.7%
5/18/2016 Reiterated Rating$425.00BuyView details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 5/18/2016
DURECT Corporation stock logo
DRRX
DURECT
$1.91
5/13/2016Reiterated Rating$40.00BuyView details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 5/13/2016
Oramed Pharmaceuticals Inc. stock logo
ORMP
Oramed Pharmaceuticals
$2.41
-0.8%
5/13/2016Reiterated Rating$25.00BuyView details for Rodman & Renshaw rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 5/13/2016
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$4.05
+4.1%
5/10/2016Reiterated RatingBuyView details for Rodman & Renshaw rating of Microbot Medical (NASDAQ:MBOT) on 5/10/2016
DarioHealth Corp. stock logo
DRIO
DarioHealth
$7.11
+0.3%
5/9/2016 Initiated Coverage$240.00BuyView details for Rodman & Renshaw rating of DarioHealth (NASDAQ:DRIO) on 5/9/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
5/3/2016Lower Price Target$105.00 ➝ $102.00BuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 5/3/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
4/26/2016Reiterated Rating$105.00BuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 4/26/2016
DURECT Corporation stock logo
DRRX
DURECT
$1.91
4/25/2016 Initiated Coverage$40.00BuyView details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 4/25/2016
Abeona Therapeutics Inc. stock logo
ABEO
Abeona Therapeutics
$6.43
-4.7%
4/20/2016 Reiterated Rating$425.00BuyView details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 4/20/2016
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$4.05
+4.1%
4/20/2016 Initiated Coverage$18.00BuyView details for Rodman & Renshaw rating of Microbot Medical (NASDAQ:MBOT) on 4/20/2016
First Majestic Silver Corp. stock logo
AG
First Majestic Silver
$10.54
+1.4%
4/15/2016 Boost Price Target$6.00 ➝ $8.75BuyView details for Rodman & Renshaw rating of First Majestic Silver (NYSE:AG) on 4/15/2016
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$29.19
+2.3%
4/15/2016 Initiated Coverage$8.00BuyView details for Rodman & Renshaw rating of Semler Scientific (NASDAQ:SMLR) on 4/15/2016
Endeavour Silver Corporation stock logo
EXK
Endeavour Silver
$6.15
+0.2%
4/12/2016 Boost Price Target$2.50 ➝ $3.40BuyView details for Rodman & Renshaw rating of Endeavour Silver (NYSE:EXK) on 4/12/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
4/11/2016Lower Price Target$118.00 ➝ $105.00BuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 4/11/2016
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$2.38
-10.2%
4/9/2016 Reiterated RatingBuyView details for Rodman & Renshaw rating of Inovio Pharmaceuticals (NASDAQ:INO) on 4/9/2016
Ekso Bionics Holdings, Inc. stock logo
EKSO
Ekso Bionics
$3.83
-2.3%
4/5/2016 Reiterated Rating$4,725.00BuyView details for Rodman & Renshaw rating of Ekso Bionics (NASDAQ:EKSO) on 4/5/2016
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
$8.19
-7.1%
4/4/2016 Initiated Coverage$52,500.00BuyView details for Rodman & Renshaw rating of Kura Oncology (NASDAQ:KURA) on 4/4/2016
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$1.81
+4.0%
4/4/2016 Initiated Coverage$35.00BuyView details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 4/4/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
4/3/2016Reiterated RatingBuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 4/3/2016
American Superconductor Corporation stock logo
AMSC
American Superconductor
$56.32
+2.9%
4/1/2016Reiterated RatingNeutralView details for Rodman & Renshaw rating of American Superconductor (NASDAQ:AMSC) on 4/1/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
3/28/2016Reiterated Rating$118.00BuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 3/28/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
3/22/2016Reiterated RatingBuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 3/22/2016
Nano Dimension Ltd. stock logo
NNDM
Nano Dimension
$1.42
-3.4%
3/21/2016 Initiated Coverage$700.00BuyView details for Rodman & Renshaw rating of Nano Dimension (NASDAQ:NNDM) on 3/21/2016
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$2.38
-10.2%
3/20/2016 Reiterated RatingBuyView details for Rodman & Renshaw rating of Inovio Pharmaceuticals (NASDAQ:INO) on 3/20/2016
CorMedix Inc stock logo
CRMD
CorMedix
$12.94
-1.1%
3/17/2016 Boost Price Target$32.50 ➝ $37.50BuyView details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 3/17/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
3/16/2016Lower Price Target$150.00 ➝ $118.00BuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 3/16/2016
McEwen Inc. stock logo
MUX
McEwen
$13.83
+0.1%
3/14/2016 Boost Price Target$13.00 ➝ $24.00View details for Rodman & Renshaw rating of McEwen (NYSE:MUX) on 3/14/2016
Inseego stock logo
INSG
Inseego
$13.31
-3.6%
3/7/2016 Lower Price Target$60.00 ➝ $30.00BuyView details for Rodman & Renshaw rating of Inseego (NASDAQ:INSG) on 3/7/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
3/2/2016Reiterated RatingBuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 3/2/2016
First Majestic Silver Corp. stock logo
AG
First Majestic Silver
$10.54
+1.4%
2/29/2016 Initiated Coverage$6.00BuyView details for Rodman & Renshaw rating of First Majestic Silver (NYSE:AG) on 2/29/2016
Endeavour Silver Corporation stock logo
EXK
Endeavour Silver
$6.15
+0.2%
2/29/2016 Initiated Coverage$2.50BuyView details for Rodman & Renshaw rating of Endeavour Silver (NYSE:EXK) on 2/29/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
2/23/2016Reiterated Rating$150.00BuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 2/23/2016
Radcom Ltd. stock logo
RDCM
Radcom
$14.59
+1.5%
2/18/2016 Boost Price Target$12.00 ➝ $16.00BuyView details for Rodman & Renshaw rating of Radcom (NASDAQ:RDCM) on 2/18/2016
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$7.27
+0.3%
2/16/2016 Initiated Coverage$150.00BuyView details for Rodman & Renshaw rating of Bausch Health Cos (NYSE:BHC) on 2/16/2016
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
$7.91
-2.0%
2/9/2016 Lower Price Target$24.00 ➝ $10.00BuyView details for Rodman & Renshaw rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 2/9/2016
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$2.38
-10.2%
1/29/2016 Reiterated RatingBuyView details for Rodman & Renshaw rating of Inovio Pharmaceuticals (NASDAQ:INO) on 1/29/2016
Ideal Power Inc. stock logo
IPWR
Ideal Power
$5.20
-0.4%
1/26/2016 Initiated Coverage$12.00BuyView details for Rodman & Renshaw rating of Ideal Power (NASDAQ:IPWR) on 1/26/2016
American Superconductor Corporation stock logo
AMSC
American Superconductor
$56.32
+2.9%
1/13/2016 Initiated Coverage$10.00BuyView details for Rodman & Renshaw rating of American Superconductor (NASDAQ:AMSC) on 1/13/2016
Oramed Pharmaceuticals Inc. stock logo
ORMP
Oramed Pharmaceuticals
$2.41
-0.8%
1/10/2016 Reiterated Rating$25.00BuyView details for Rodman & Renshaw rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 1/10/2016
Microvision, Inc. stock logo
MVIS
Microvision
$1.14
-0.9%
12/17/2015 Initiated Coverage$3.50BuyView details for Rodman & Renshaw rating of Microvision (NASDAQ:MVIS) on 12/17/2015
CorMedix Inc stock logo
CRMD
CorMedix
$12.94
-1.1%
12/16/2015 Initiated CoverageBuyView details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 12/16/2015
Vuzix Corporation stock logo
VUZI
Vuzix
$2.23
-5.5%
12/10/2015 Initiated Coverage$10.00BuyView details for Rodman & Renshaw rating of Vuzix (NASDAQ:VUZI) on 12/10/2015
CorMedix Inc stock logo
CRMD
CorMedix
$12.94
-1.1%
11/12/2015 Initiated Coverage$32.50BuyView details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 11/12/2015
Ballard Power Systems, Inc. stock logo
BLDP
Ballard Power Systems
$2.07
+1.0%
10/5/2015 Reiterated RatingBuyView details for Rodman & Renshaw rating of Ballard Power Systems (NASDAQ:BLDP) on 10/5/2015
Oramed Pharmaceuticals Inc. stock logo
ORMP
Oramed Pharmaceuticals
$2.41
-0.8%
10/1/2015 Initiated Coverage$24.00BuyView details for Rodman & Renshaw rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 10/1/2015
Ballard Power Systems, Inc. stock logo
BLDP
Ballard Power Systems
$2.07
+1.0%
8/20/2015 Initiated Coverage$2.50BuyView details for Rodman & Renshaw rating of Ballard Power Systems (NASDAQ:BLDP) on 8/20/2015
Gevo, Inc. stock logo
GEVO
Gevo
$1.67
+0.6%
8/19/2015 Initiated Coverage$100.00BuyView details for Rodman & Renshaw rating of Gevo (NASDAQ:GEVO) on 8/19/2015
Energy Focus, Inc. stock logo
EFOI
Energy Focus
$2.48
8/7/2015 Initiated Coverage$630.00BuyView details for Rodman & Renshaw rating of Energy Focus (NASDAQ:EFOI) on 8/7/2015
Ballard Power Systems, Inc. stock logo
BLDP
Ballard Power Systems
$2.07
+1.0%
7/14/2015 Initiated CoverageBuyView details for Rodman & Renshaw rating of Ballard Power Systems (NASDAQ:BLDP) on 7/14/2015
Energy Focus, Inc. stock logo
EFOI
Energy Focus
$2.48
6/25/2015 Initiated CoverageBuyView details for Rodman & Renshaw rating of Energy Focus (NASDAQ:EFOI) on 6/25/2015
Catalyst Pharmaceuticals, Inc. stock logo
CPRX
Catalyst Pharmaceuticals
$19.97
-1.4%
8/27/2012 Upgrade$3.70Market PerformOutperformView details for Rodman & Renshaw rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 8/27/2012
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$51.13
-4.1%
7/31/2012 Reiterated Rating$2.00OutperformView details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 7/31/2012
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$465.89
-0.6%
7/31/2012 Reiterated Rating$22.00OutperformView details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 7/31/2012
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$46.22
-2.8%
7/27/2012 Boost Price Target$38.00 ➝ $39.50OutperformView details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 7/27/2012
Amgen Inc. stock logo
AMGN
Amgen
$276.39
-2.2%
7/23/2012 Boost Price Target$73.00 ➝ $89.00OutperformView details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 7/23/2012
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$465.89
-0.6%
7/16/2012 Reiterated RatingOutperformView details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 7/16/2012
Allegiant Travel Company stock logo
ALGT
Allegiant Travel
$64.74
0.0%
7/13/2012 Boost Price Target$72.00 ➝ $79.00OutperformView details for Rodman & Renshaw rating of Allegiant Travel (NASDAQ:ALGT) on 7/13/2012
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$46.22
-2.8%
7/5/2012 Reiterated Rating$38.00Market PerformView details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 7/5/2012
Assembly Biosciences, Inc. stock logo
ASMB
Assembly Biosciences
$21.85
-3.3%
6/26/2012 Lower Price Target$132.00View details for Rodman & Renshaw rating of Assembly Biosciences (NASDAQ:ASMB) on 6/26/2012
Amgen Inc. stock logo
AMGN
Amgen
$276.39
-2.2%
6/21/2012 Boost Price Target$57.00 ➝ $73.00OutperformView details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 6/21/2012
Ducommun Incorporated stock logo
DCO
Ducommun
$93.10
-0.1%
5/24/2012 Initiated CoverageMarket PerformView details for Rodman & Renshaw rating of Ducommun (NYSE:DCO) on 5/24/2012
Powell Industries, Inc. stock logo
POWL
Powell Industries
$287.68
-1.6%
5/10/2012 Upgrade$43.00Market PerformOutperformView details for Rodman & Renshaw rating of Powell Industries (NASDAQ:POWL) on 5/10/2012
Enpro Inc. stock logo
NPO
Enpro
$222.00
-2.9%
5/4/2012 Boost Price Target$47.00 ➝ $50.00OutperformView details for Rodman & Renshaw rating of Enpro (NYSE:NPO) on 5/4/2012
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$1.62
-4.1%
4/24/2012 Initiated Coverage$176.00OutperformView details for Rodman & Renshaw rating of Rockwell Medical (NASDAQ:RMTI) on 4/24/2012
Stryker Corporation stock logo
SYK
Stryker
$383.32
-1.4%
4/20/2012 DowngradeOutperformMarket PerformView details for Rodman & Renshaw rating of Stryker (NYSE:SYK) on 4/20/2012
Insulet Corporation stock logo
PODD
Insulet
$341.78
+1.1%
4/18/2012 UpgradeMarket PerformOutperformView details for Rodman & Renshaw rating of Insulet (NASDAQ:PODD) on 4/18/2012
TriMas Corporation stock logo
TRS
TriMas
$39.00
-0.5%
3/15/2012 Initiated Coverage$32.00OutperformView details for Rodman & Renshaw rating of TriMas (NASDAQ:TRS) on 3/15/2012
Omeros Corporation stock logo
OMER
Omeros
$4.15
-1.2%
3/13/2012 Boost Price Target$13.00 ➝ $16.00OutperformView details for Rodman & Renshaw rating of Omeros (NASDAQ:OMER) on 3/13/2012
Amgen Inc. stock logo
AMGN
Amgen
$276.39
-2.2%
3/7/2012 Reiterated Rating$57.00OutperformView details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 3/7/2012
Verastem, Inc. stock logo
VSTM
Verastem
$9.72
+4.0%
3/7/2012 Initiated CoverageBuyMarket PerformView details for Rodman & Renshaw rating of Verastem (NASDAQ:VSTM) on 3/7/2012
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
$97.71
-1.0%
2/27/2012 Reiterated RatingMarket PerformView details for Rodman & Renshaw rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 2/27/2012
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
$432.22
-1.6%
2/22/2012 Reiterated Rating$8.00Market PerformView details for Rodman & Renshaw rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 2/22/2012
Magic Software Enterprises Ltd. stock logo
MGIC
Magic Software Enterprises
$20.43
2/15/2012 Boost Price Target$8.00 ➝ $10.00OutperformView details for Rodman & Renshaw rating of Magic Software Enterprises (NASDAQ:MGIC) on 2/15/2012
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$465.89
-0.6%
2/6/2012 Boost Price Target$19.00OutperformView details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/6/2012
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
$59.94
-0.8%
2/6/2012 Reiterated Rating$14.00OutperformView details for Rodman & Renshaw rating of Delta Air Lines (NYSE:DAL) on 2/6/2012
Allegiant Travel Company stock logo
ALGT
Allegiant Travel
$64.74
0.0%
2/2/2012 Boost Price Target$62.00View details for Rodman & Renshaw rating of Allegiant Travel (NASDAQ:ALGT) on 2/2/2012
Powell Industries, Inc. stock logo
POWL
Powell Industries
$287.68
-1.6%
1/26/2012 Initiated CoverageMarket PerformView details for Rodman & Renshaw rating of Powell Industries (NASDAQ:POWL) on 1/26/2012
Silicom Ltd stock logo
SILC
Silicom
$18.30
-0.5%
1/24/2012 Boost Price Target$20.00 ➝ $25.00OutperformView details for Rodman & Renshaw rating of Silicom (NASDAQ:SILC) on 1/24/2012
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$46.22
-2.8%
1/23/2012 Reiterated Rating$51.00OutperformView details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 1/23/2012
Southwest Airlines Co. stock logo
LUV
Southwest Airlines
$31.69
-0.1%
1/20/2012 Reiterated Rating$12.00OutperformView details for Rodman & Renshaw rating of Southwest Airlines (NYSE:LUV) on 1/20/2012
Amgen Inc. stock logo
AMGN
Amgen
$276.39
-2.2%
1/17/2012 Reiterated Rating$57.00OutperformView details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 1/17/2012
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
$432.22
-1.6%
1/5/2012 Initiated Coverage$8.00OutperformView details for Rodman & Renshaw rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 1/5/2012
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$465.89
-0.6%
1/4/2012 Reiterated Rating$12.00OutperformView details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 1/4/2012
Woodward, Inc. stock logo
WWD
Woodward
$238.17
-0.8%
1/4/2012 Initiated Coverage$52.00OutperformView details for Rodman & Renshaw rating of Woodward (NASDAQ:WWD) on 1/4/2012
Amgen Inc. stock logo
AMGN
Amgen
$276.39
-2.2%
12/23/2011 Reiterated Rating$57.00OutperformView details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 12/23/2011
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
$97.71
-1.0%
12/15/2011 DowngradeOutperformMarket PerformView details for Rodman & Renshaw rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 12/15/2011
Intel Corporation stock logo
INTC
Intel
$24.08
-2.2%
12/13/2011 Reiterated Rating$27.00OutperformView details for Rodman & Renshaw rating of Intel (NASDAQ:INTC) on 12/13/2011
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$46.22
-2.8%
12/13/2011 Lower Price Target$51.00View details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 12/13/2011
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$465.89
-0.6%
12/12/2011 Reiterated Rating$12.00OutperformView details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 12/12/2011
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$46.22
-2.8%
12/12/2011 Reiterated Rating$52.50OutperformView details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 12/12/2011
Omeros Corporation stock logo
OMER
Omeros
$4.15
-1.2%
12/5/2011 Upgrade$13.00Market PerformOutperformView details for Rodman & Renshaw rating of Omeros (NASDAQ:OMER) on 12/5/2011
Rogers Corporation stock logo
ROG
Rogers
$81.11
-3.4%
12/2/2011 Initiated Coverage$55.00OutperformView details for Rodman & Renshaw rating of Rogers (NYSE:ROG) on 12/2/2011
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$465.89
-0.6%
12/1/2011 Reiterated RatingOutperformView details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 12/1/2011
Amgen Inc. stock logo
AMGN
Amgen
$276.39
-2.2%
12/1/2011 Initiated Coverage$62.00OutperformView details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 12/1/2011
Curis, Inc. stock logo
CRIS
Curis
$1.82
11/30/2011 Reiterated Rating$600.00OutperformView details for Rodman & Renshaw rating of Curis (NASDAQ:CRIS) on 11/30/2011
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$77.50
-0.7%
11/29/2011 Reiterated RatingMarket PerformView details for Rodman & Renshaw rating of Edwards Lifesciences (NYSE:EW) on 11/29/2011
Apple Inc. stock logo
AAPL
Apple
$234.07
+1.8%
11/29/2011 Reiterated Rating$16.07OutperformView details for Rodman & Renshaw rating of Apple (NASDAQ:AAPL) on 11/29/2011
Southwest Airlines Co. stock logo
LUV
Southwest Airlines
$31.69
-0.1%
11/21/2011 Reiterated Rating$12.00OutperformView details for Rodman & Renshaw rating of Southwest Airlines (NYSE:LUV) on 11/21/2011
Dell Technologies Inc. stock logo
DELL
Dell Technologies
$124.98
-0.3%
11/15/2011 Reiterated Rating$18.00OutperformView details for Rodman & Renshaw rating of Dell Technologies (NYSE:DELL) on 11/15/2011
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$77.50
-0.7%
11/11/2011 Reiterated RatingMarket PerformView details for Rodman & Renshaw rating of Edwards Lifesciences (NYSE:EW) on 11/11/2011
Adient stock logo
ADNT
Adient
$24.00
-2.6%
11/11/2011 Initiated CoverageMarket PerformView details for Rodman & Renshaw rating of Adient (NYSE:ADNT) on 11/11/2011
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$465.89
-0.6%
11/10/2011 Reiterated RatingOutperformView details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 11/10/2011
Intel Corporation stock logo
INTC
Intel
$24.08
-2.2%
11/10/2011 Reiterated RatingOutperformView details for Rodman & Renshaw rating of Intel (NASDAQ:INTC) on 11/10/2011
Curis, Inc. stock logo
CRIS
Curis
$1.82
11/10/2011 Reiterated Rating$600.00OutperformView details for Rodman & Renshaw rating of Curis (NASDAQ:CRIS) on 11/10/2011
Apple Inc. stock logo
AAPL
Apple
$234.07
+1.8%
11/9/2011 Reiterated RatingOutperformView details for Rodman & Renshaw rating of Apple (NASDAQ:AAPL) on 11/9/2011
Geron Corporation stock logo
GERN
Geron
$1.27
-3.8%
11/9/2011 Lower Price Target$4.00View details for Rodman & Renshaw rating of Geron (NASDAQ:GERN) on 11/9/2011
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$46.22
-2.8%
11/9/2011 Reiterated Rating$52.50OutperformView details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 11/9/2011
U.S. Energy Corp. stock logo
USEG
U.S. Energy
$1.15
+1.8%
11/8/2011 Reiterated Rating$47.50OutperformView details for Rodman & Renshaw rating of U.S. Energy (NASDAQ:USEG) on 11/8/2011
Energy Recovery, Inc. stock logo
ERII
Energy Recovery
$14.36
-1.2%
11/4/2011 Reiterated RatingMarket PerformView details for Rodman & Renshaw rating of Energy Recovery (NASDAQ:ERII) on 11/4/2011
AudioCodes Ltd. stock logo
AUDC
AudioCodes
$10.20
-2.4%
11/1/2011 Reiterated RatingOutperformView details for Rodman & Renshaw rating of AudioCodes (NASDAQ:AUDC) on 11/1/2011
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$51.13
-4.1%
11/1/2011 Reiterated Rating$4.00OutperformView details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 11/1/2011
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$465.89
-0.6%
11/1/2011 Reiterated Rating$12.00OutperformView details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 11/1/2011
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$46.22
-2.8%
10/28/2011 Reiterated Rating$52.50OutperformView details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 10/28/2011
Ceva, Inc. stock logo
CEVA
Ceva
$23.61
-1.0%
10/27/2011 Reiterated RatingOutperformView details for Rodman & Renshaw rating of Ceva (NASDAQ:CEVA) on 10/27/2011
Allegiant Travel Company stock logo
ALGT
Allegiant Travel
$64.74
0.0%
10/27/2011 Reiterated RatingOutperformView details for Rodman & Renshaw rating of Allegiant Travel (NASDAQ:ALGT) on 10/27/2011
JetBlue Airways Corporation stock logo
JBLU
JetBlue Airways
$5.05
-2.9%
10/27/2011 Reiterated Rating$6.00Market PerformView details for Rodman & Renshaw rating of JetBlue Airways (NASDAQ:JBLU) on 10/27/2011
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
$59.94
-0.8%
10/26/2011 Boost Price Target$14.00View details for Rodman & Renshaw rating of Delta Air Lines (NYSE:DAL) on 10/26/2011
Southwest Airlines Co. stock logo
LUV
Southwest Airlines
$31.69
-0.1%
10/21/2011 Reiterated RatingOutperformView details for Rodman & Renshaw rating of Southwest Airlines (NYSE:LUV) on 10/21/2011
Alaska Air Group, Inc. stock logo
ALK
Alaska Air Group
$63.40
-0.7%
10/21/2011 Reiterated Rating$39.00OutperformView details for Rodman & Renshaw rating of Alaska Air Group (NYSE:ALK) on 10/21/2011
Intel Corporation stock logo
INTC
Intel
$24.08
-2.2%
10/19/2011 Reiterated Rating$27.00OutperformView details for Rodman & Renshaw rating of Intel (NASDAQ:INTC) on 10/19/2011
Apple Inc. stock logo
AAPL
Apple
$234.07
+1.8%
10/19/2011 Reiterated RatingOutperformView details for Rodman & Renshaw rating of Apple (NASDAQ:AAPL) on 10/19/2011
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$465.89
-0.6%
10/14/2011 Initiated Coverage$12.00OutperformView details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 10/14/2011
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$46.22
-2.8%
10/14/2011 Initiated Coverage$52.50OutperformView details for Rodman & Renshaw rating of Bristol Myers Squibb (NYSE:BMY) on 10/14/2011
Enpro Inc. stock logo
NPO
Enpro
$222.00
-2.9%
10/13/2011 Initiated Coverage$47.00OutperformView details for Rodman & Renshaw rating of Enpro (NYSE:NPO) on 10/13/2011
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$51.13
-4.1%
10/13/2011 Initiated Coverage$4.00OutperformView details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 10/13/2011
Ceva, Inc. stock logo
CEVA
Ceva
$23.61
-1.0%
10/7/2011 Reiterated Rating$36.00OutperformView details for Rodman & Renshaw rating of Ceva (NASDAQ:CEVA) on 10/7/2011
Apple Inc. stock logo
AAPL
Apple
$234.07
+1.8%
10/5/2011 Reiterated Rating$16.07OutperformView details for Rodman & Renshaw rating of Apple (NASDAQ:AAPL) on 10/5/2011
Intel Corporation stock logo
INTC
Intel
$24.08
-2.2%
10/3/2011 Reiterated RatingOutperformView details for Rodman & Renshaw rating of Intel (NASDAQ:INTC) on 10/3/2011
Agenus Inc. stock logo
AGEN
Agenus
$4.48
-5.5%
9/26/2011 Reiterated Rating$40.00OutperformView details for Rodman & Renshaw rating of Agenus (NASDAQ:AGEN) on 9/26/2011
Silicom Ltd stock logo
SILC
Silicom
$18.30
-0.5%
9/8/2011 Initiated Coverage$20.00OutperformView details for Rodman & Renshaw rating of Silicom (NASDAQ:SILC) on 9/8/2011
Stryker Corporation stock logo
SYK
Stryker
$383.32
-1.4%
8/15/2011 Upgrade$56.00Market PerformOutperformView details for Rodman & Renshaw rating of Stryker (NYSE:SYK) on 8/15/2011
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$77.50
-0.7%
8/15/2011 Upgrade$11.00UnderperformMarket PerformView details for Rodman & Renshaw rating of Edwards Lifesciences (NYSE:EW) on 8/15/2011
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
$53.94
-3.7%
8/15/2011 Upgrade$7.00 ➝ $12.00Market PerformOutperformView details for Rodman & Renshaw rating of Exact Sciences (NASDAQ:EXAS) on 8/15/2011
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
$53.94
-3.7%
8/3/2011 DowngradeOutperformMarket PerformView details for Rodman & Renshaw rating of Exact Sciences (NASDAQ:EXAS) on 8/3/2011
Wolfspeed stock logo
WOLF
Wolfspeed
$2.33
+23.9%
8/2/2011 Upgrade$5.00Market PerformOutperformView details for Rodman & Renshaw rating of Wolfspeed (NYSE:WOLF) on 8/2/2011
Energy Recovery, Inc. stock logo
ERII
Energy Recovery
$14.36
-1.2%
7/28/2011 Initiated CoverageMarket PerformView details for Rodman & Renshaw rating of Energy Recovery (NASDAQ:ERII) on 7/28/2011
Insulet Corporation stock logo
PODD
Insulet
$341.78
+1.1%
7/25/2011 Downgrade$18.00Market PerformUnderperformView details for Rodman & Renshaw rating of Insulet (NASDAQ:PODD) on 7/25/2011
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$77.50
-0.7%
7/25/2011 Downgrade$11.00Market PerformUnderperformView details for Rodman & Renshaw rating of Edwards Lifesciences (NYSE:EW) on 7/25/2011
Wynn Resorts, Limited stock logo
WYNN
Wynn Resorts
$121.45
-1.9%
7/19/2011 Boost Price Target$160.00 ➝ $177.00OutperformView details for Rodman & Renshaw rating of Wynn Resorts (NASDAQ:WYNN) on 7/19/2011

MarketBeat Community Rating for Rodman & Renshaw

Community Ranking:  2.6 out of 5 (
2.6 of 5 stars)
Outperform Votes:  52,818 (Vote Outperform)
Underperform Votes:  50,265 (Vote Underperform)
Total Votes:  103,083
MarketBeat's community ratings are surveys of what our community members think about Rodman & Renshaw and other research firms. Vote "Outperform" if you believe Rodman & Renshaw's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Rodman & Renshaw's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.